Buzz Stocks: Goldman Sachs Group Inc, Heron Therapeutics Inc, and Sunedison Inc

Today's stocks to watch in the news include Goldman Sachs Group Inc (GS), Heron Therapeutics Inc (HRTX), and Sunedison Inc (SUNE)

Apr 19, 2016 at 9:28 AM

U.S. stocks are set to open higher, thanks to a rebound in crude oil prices. Among equities in focus today are financial firm Goldman Sachs Group Inc (NYSE:GS), drugmaker Heron Therapeutics Inc (NASDAQ:HRTX), and solar stock Sunedison Inc (NYSE:SUNE).

GS reported a slump in earnings for the fourth straight quarter, though its per-share profit still topped estimates. Meanwhile, the bank's revenue dropped roughly 40% year-over-year -- to the lowest level in more than four years -- and came up short of the Street's consensus view. The collective news has Goldman Sachs Group Inc ready to steepen its nearly 12% year-to-date deficit, off 0.4% ahead of the bell, after closing at $159.02 last night. Heading into the event, short-term options traders were extremely call-skewed. Meanwhile, short sellers have been heading to the sidelines. During the most recent reporting period, short interest on GS plummeted 43%, and now less than 1% of the stock's float is sold short.

HRTX is ready to explode 16.8% higher out of the gate, after the U.S. Food and Drug Administration (FDA) said there were no deficiencies in the biotech's marketing application for anti-vomiting drug Sustol, and added that labeling talks have commenced. Today's expected bull gap will help close Heron Therapeutics Inc's year-to-date hole of 19.5%, which has the stock resting at $21.49. On the sentiment front, analysts are all in on HRTX, as 100% consider the shares worthy of a "strong buy" endorsement.

Activist investor David Einhorn and his hedge fund Greenlight Capital have each slashed their stakes in SUNE, according to recent SEC filings. The news is drilling the stock in pre-market trading, with Sunedison Inc down 3.1% after closing Monday at $0.34. Of course, the shares are no stranger to big losses, losing nearly all of their value over the past few months amid mounting bankruptcy buzz. Meanwhile, short-term options traders have grown extremely put-skewed toward SUNE. The stock's Schaeffer's put/call open interest ratio (SOIR) registers at an annual high of 1.64.

Sign up now for Schaeffer's Opening View newsletter to get a head start on all the major pre-market news!

Follow @Schaeffers

Which of These SUB-$5 Stocks Could 26x From Here? (AD)

He called a rare 11x on Tesla…

Then he called a 26x on Workhorse…

Then an even rarer 35x on Nio Inc…

Now Tim Bohen says these 5 tiny “America First” stocks are next up in 2025.

They’re trading for less than $5 right now.

But thanks to Elon & Trump’s new alliance…

They could be off to the races in Trump’s first 100 days.

And right now for a limited time…

You can get the names & tickers for just $1 here. (AD)

Featured Articles from Trusted Partners:

🚀 One Stock Pick Could Change Everything in 2025
What if one stock pick could define your success next year? Get 10 expert-vetted stocks set for 2025—plus 5 bonus picks to watch now. Get the Report →

🆕 New Options Need New Trading Strategies
Zero-DTE options are the newest (and hottest) options to trade. Professional traders have rushed into the market and are making a mint. Don’t get left behind - learn all about these options, how to trade them, market setups to profit from, plus much more. Download now →

👀 Revealed: 3 Defensive Stocks for Your Portfolio
Worried about the market? This free report reveals 3 under-the-radar defensive stocks for uncertain times in any kind of economy.